Bharat Serums and Vaccines
VC Fund
Mumbai, India
Bharat Serums and Vaccines is a biopharmaceutical company focused on creating innovative treatments in women's health and critical care. The company offers a diverse range of products, including plasma derivatives and monoclonal antibodies, aimed at addressing various medical conditions. With a strong emphasis on research and development,Bharat Serums and Vaccines strives to enhance accessibility and improve patient outcomes globally.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Bharat Serums and Vaccines invests in
Stages Bharat Serums and Vaccines invests in
Countries Bharat Serums and Vaccines invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Solar 1 (50%)
- Energy 1 (50%)
- Advertising 1 (50%)
- Social Media 1 (50%)
- Renewable Energy 1 (50%)
Stage
- Seed 1 (50%)
- Corporate Round 1 (50%)
Country
- India 1 (50%)
- Canada 1 (50%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
BHARAT V. DAFTARY
Chairman & Managing Director
|
Chairman & Managing Director | Total investments: 1 | Find email | |
|
Chirag Mehta
Chief Financial Officer
|
Chief Financial Officer | Total investments: 0 | Find email | |
|
Gautam Daftary
Vice Chairman & Managing Director
|
Vice Chairman & Managing Director | Total investments: 0 | Find email | |
|
Nilesh Kulkarni
Chief Human Resource Officer
|
Chief Human Resource Officer | Total investments: 0 | Find email | |
|
Rahul Adakmol
COO (International Operations & Business Development)
|
COO (International Operations & Business Development) | Total investments: 0 | Find email | |
| See all 8 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Digimaze is an Adtech performance marketing firm. | $700K / Seed / Mar 29, 2022 | |
|
|
They build, own and operate clean energy assets both behind and in front of the meter. Their solutions, managed by proprietary, technology-enabled risk management tools, allow us to provide dispatchable, affordable and resilient clean power to enhance system reliability and security for their customers and the grid. | Corporate Round / Mar 16, 2022 |
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Featured in Investor Lists
Recommended lists
FAQ
What does Bharat Serums and Vaccines invest in?
Bharat Serums and Vaccines invests primarily in Solar, Energy and Advertising startups, most often at Seed and Corporate Round stage. Most of the 2 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Bharat Serums and Vaccines?
Public channels for Bharat Serums and Vaccines include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Bharat Serums and Vaccines?
The team at Bharat Serums and Vaccines includes BHARAT V. DAFTARY (Chairman & Managing Director), Chirag Mehta (Chief Financial Officer) and Gautam Daftary (Vice Chairman & Managing Director), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!